Robert C. Kalayjian
- Virology top 0.5%
- HIV Research and Treatment 26
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 17
-
- Antibiotic Use and Resistance 7
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 33
- Infectious Diseases top 1%
- HIV/AIDS Research and Interventions 28
- HIV/AIDS drug development and treatment 25
-
- Antibiotics Pharmacokinetics and Efficacy 12
-
- Pneumocystis jirovecii pneumonia detection and treatment 9
Robert C. Kalayjian
78 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Virology 937
- Molecular Medicine 888
- Applied Microbiology and Biotechnology 351
- Emergency Medicine 1.2k
- Infectious Diseases 1.5k
Countries citing papers authored by Robert C. Kalayjian
This map shows the geographic impact of Robert C. Kalayjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Kalayjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Kalayjian more than expected).
Fields of papers citing papers by Robert C. Kalayjian
This network shows the impact of papers produced by Robert C. Kalayjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Kalayjian. The network helps show where Robert C. Kalayjian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert C. Kalayjian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 12 | |
| 4 | 2018 | 7 | |
| 5 | 2017 | 63 | |
| 6 | 2017 | 16 | |
| 7 | 2017 | 43 | |
| 8 | 2016 | 80 | |
| 9 | 2015 | 23 | |
| 10 | 2013 | 10 | |
| 11 | 2010 | 29 | |
| 12 | 2008 | 90 | |
| 13 | 2005 | 30 | |
| 14 | 2004 | 256 | |
| 15 | 2003 | 146 | |
| 16 | 2003 | 39 | |
| 17 | 2003 | 121 | |
| 18 | 1998 | 16 | |
| 19 | 1996 | 96 | |
| 20 | 1988 | 12 |
About Robert C. Kalayjian
Robert C. Kalayjian is a scholar working on Virology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 82 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (33 papers), HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (25 papers), Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Antibiotic Use and Resistance (7 papers). The work is most often cited by research in Virology (937 citations), Molecular Medicine (888 citations) and Applied Microbiology and Biotechnology (351 citations). Robert C. Kalayjian has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Robert A. Salata, Robert A. Bonomo, Samir K. Gupta, Michael M. Lederman, David van Duin, Keith S. Kaye, Eric Cober, Scott Evans, Vance G. Fowler and Sandra S. Richter. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.